Yamamoto A, Matsuzawa Y, Kishino B, Hayashi R, Hirobe K, Kikkawa T
Atherosclerosis. 1983 Aug;48(2):157-66. doi: 10.1016/0021-9150(83)90102-8.
A marked reduction of serum cholesterol was obtained by treatment with probucol in heterozygous as well as in homozygous cases of familial hypercholesterolemia. A strict dietary regimen (low-fat, low-calories) intensified the hypocholesterolemic effect of the drug. The drug was also useful in diminishing the rebound of serum cholesterol after plasma exchange. Probucol reduced serum triglycerides in heterozygous cases of familial hypercholesterolemia, but there was a slight increase in triglycerides in homozygous cases. Treatment with probucol resulted in the regression of cutaneous and tendon xanthomas. Although it caused a decrease in HDL, it seems to be very effective in the treatment of familial hypercholesterolemia.
用普罗布考治疗杂合子及纯合子家族性高胆固醇血症患者,可使血清胆固醇显著降低。严格的饮食方案(低脂、低热量)可增强该药的降胆固醇作用。该药还可用于减轻血浆置换后血清胆固醇的反弹。普罗布考可降低杂合子家族性高胆固醇血症患者的血清甘油三酯,但在纯合子患者中甘油三酯略有升高。用普罗布考治疗可使皮肤和肌腱黄色瘤消退。尽管它会导致高密度脂蛋白降低,但在治疗家族性高胆固醇血症方面似乎非常有效。